Helus Pharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Helus Pharma and other ETFs, options, and stocks.About HELP
Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds.
HELP Key Statistics
Stock Snapshot
With a market cap of 860.65M, Helus Pharma(HELP) trades at $11.95. The stock has a price-to-earnings ratio of -2.78.
On 2026-10-12, Helus Pharma(HELP) stock moved within a range of $10.45 to $12.09. With shares now at $11.95, the stock is trading +14.4% above its intraday low and -1.2% below the session's peak.
Trading volume for Helus Pharma(HELP) stock has reached 1.66M, versus its average volume of 1.19M.
Over the past 52 weeks, Helus Pharma(HELP) stock has traded between a high of $15.15 and a low of $3.76.
Over the past 52 weeks, Helus Pharma(HELP) stock has traded between a high of $15.15 and a low of $3.76.
Analyst ratings
100%
of 11 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.